Time to buy or time to flee???, page-39

Thanks Whytee,

But that is at such an early stage to be honest it is hardly worth mentioning.

I know it has hit the media, but The Daily Mail has a this could be terrible for you or this could be the best thing ever story every day imho.

Serious competition might come from the likes of ASX listed Imugene and the B cell therapies in the future, but I believe that vla has the most compelling product for a lucrative market right now.

Cheers